Higher BMI is not a barrier to stem cell mobilization with standard doses of plerixafor and G-CSF-Reference-Cited by-同舟云学术

Higher BMI is not a barrier to stem cell mobilization with standard doses of plerixafor and G-CSF

Published:2011-10-10 Issue:7 Volume:47 Page:1003-1005
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Basak G W,Wiktor-Jedrzejczak W,Apperley J F,Douglas K W,Gabriel I H,Geraldes C,Hübel K,Jaksic O,Koristek Z,Lanza F,Lemoli R,Mikala G,Selleslag D,Worel N,Mohty M,Duarte R F

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/bmt2011199.pdf

Reference10 articles.

1. WHO. Physical Status: The Use and Interpretation of Anthropometry. Report of a WHO Expert Committee. WHO Technical Report Series 854. World Health Organization: Geneva, 1995.

2. Selassie M, Sinha AC . The epidemiology and aetiology of obesity: a global challenge. Best Pract Res Clin Anaesthesiol 2011; 25: 1–9.

3. Suzuya H, Watanabe T, Nakagawa R, Watanabe H, Okamoto Y, Onishi T et al. Factors associated with granulocyte colony-stimulating factor-induced peripheral blood stem cell yield in healthy donors. Vox Sang 2005; 89: 229–235.

4. Wang TF, Wen SH, Chen RL, Lu CJ, Zheng YJ, Yang SH et al. Factors associated with peripheral blood stem cell yield in volunteer donors mobilized with granulocyte colony-stimulating factors: the impact of donor characteristics and procedural settings. Biol Blood Marrow Transplant 2008; 14: 1305–1311.

5. Cetin T, Arpaci F, Ozet A, Oztürk B, Kömürcü S, Ihsan Uzar A et al. Stem cell mobilization by G-CSF in solid and hematological malignancies: single daily dose is better than split dose in obese patients. J Clin Apher 2003; 18: 120–124.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of body mass index (BMI) on the efficacy of plerixafor for hematopoietic progenitor cell (HPC) mobilization;Bone Marrow Transplantation;2022-04-25

2. Long-acting granulocyte colony-stimulating factor pegfilgrastim (lipegfilgrastim) for stem cell mobilization in multiple myeloma patients undergoing autologous stem cell transplantation;International Journal of Hematology;2021-07-02

3. Weighty choices: selecting optimal G-CSF doses for stem cell mobilization to optimize yield;Blood Advances;2020-02-24

4. Body mass index does not impact hematopoietic progenitor cell mobilization for autologous hematopoietic cell transplantation;Journal of Clinical Apheresis;2019-08-05

5. Dose capping of plerixafor in patients weighing more than 100 kg at one vial led to successful mobilization outcomes and significant cost savings;Transfusion;2017-11-13